Sedana Medical AB (publ) (STO:SEDANA)
Sweden
· Delayed Price · Currency is SEK 9.00
-0.24 (-2.60%)
Mar 9, 2026, 5:29 PM CET
Sedana Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 200.23 | 178.75 | 153.87 | 122.87 | 159.15 | Upgrade
|
| Revenue Growth (YoY) | 12.01% | 16.17% | 25.23% | -22.80% | 12.26% | Upgrade
|
| Cost of Revenue | 57.52 | 52.61 | 44.89 | 36.79 | 52.45 | Upgrade
|
| Gross Profit | 142.71 | 126.14 | 108.98 | 86.07 | 106.71 | Upgrade
|
| Selling, General & Admin | 154.66 | 156.6 | 154.74 | 169.94 | 148.31 | Upgrade
|
| Research & Development | 20.62 | 20.29 | 20.81 | 19.94 | 19.7 | Upgrade
|
| Other Operating Expenses | 0.25 | 0.03 | -0.02 | 0.12 | -0.11 | Upgrade
|
| Operating Expenses | 175.52 | 176.92 | 175.53 | 190.01 | 167.9 | Upgrade
|
| Operating Income | -32.82 | -50.78 | -66.55 | -103.93 | -61.2 | Upgrade
|
| Interest Expense | -3.38 | -0.18 | -0.22 | -0.26 | -0.24 | Upgrade
|
| Interest & Investment Income | - | 16.49 | 15.17 | 3.58 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -22.48 | 24.52 | -7.42 | 27.68 | 4.07 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.41 | -0 | - | - | - | Upgrade
|
| Pretax Income | -57.26 | -9.95 | -59.02 | -72.93 | -57.37 | Upgrade
|
| Income Tax Expense | 1.98 | 0.73 | 0.59 | 0.57 | 0.6 | Upgrade
|
| Net Income | -59.24 | -10.67 | -59.61 | -73.51 | -57.97 | Upgrade
|
| Net Income to Common | -59.24 | -10.67 | -59.61 | -73.51 | -57.97 | Upgrade
|
| Shares Outstanding (Basic) | 99 | 99 | 99 | 99 | 93 | Upgrade
|
| Shares Outstanding (Diluted) | 99 | 99 | 99 | 99 | 93 | Upgrade
|
| Shares Change (YoY) | - | - | - | 6.85% | 1.54% | Upgrade
|
| EPS (Basic) | -0.60 | -0.11 | -0.60 | -0.74 | -0.62 | Upgrade
|
| EPS (Diluted) | -0.60 | -0.11 | -0.60 | -0.74 | -0.62 | Upgrade
|
| Free Cash Flow | -15.18 | -13.99 | -38.58 | -116.17 | -46.41 | Upgrade
|
| Free Cash Flow Per Share | -0.15 | -0.14 | -0.39 | -1.17 | -0.50 | Upgrade
|
| Gross Margin | 71.27% | 70.57% | 70.83% | 70.06% | 67.05% | Upgrade
|
| Operating Margin | -16.39% | -28.41% | -43.25% | -84.59% | -38.45% | Upgrade
|
| Profit Margin | -29.59% | -5.97% | -38.74% | -59.83% | -36.42% | Upgrade
|
| Free Cash Flow Margin | -7.58% | -7.82% | -25.07% | -94.55% | -29.16% | Upgrade
|
| EBITDA | -10.78 | -48.77 | -64.19 | -100.56 | -56.8 | Upgrade
|
| EBITDA Margin | -5.38% | -27.28% | -41.72% | -81.84% | -35.69% | Upgrade
|
| D&A For EBITDA | 22.04 | 2.01 | 2.36 | 3.38 | 4.4 | Upgrade
|
| EBIT | -32.82 | -50.78 | -66.55 | -103.93 | -61.2 | Upgrade
|
| EBIT Margin | -16.39% | -28.41% | -43.25% | -84.59% | -38.45% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.